Full Professor(heuristic)

Epigenetics and DNA Methylation · Molecular Biology

Compare more Molecular Biology professors.

h-index60
i10-index110
Publications230
Citations16,229

Grants

6 total · 1 active

NIH #R01HD112473

Role of PRMT7 in Genomic Imprinting

Active
Amount
$300K–$400K
Period
2023-08-17 → 2027-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA277152

Preclinical studies of non-nucleoside DNMT3A/3B inhibitors

Amount
$200K–$300K
Period
2023-12-19 → 2025-11-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01HL149751

Epigenetic regulation of thrombopoiesis

Amount
$300K–$400K
Period
2020-01-01 → 2022-12-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 1 active

NIH #R01HD112473

Role of PRMT7 in Genomic Imprinting

Active
Amount
$300K–$400K
Period
2023-08-17 → 2027-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R21CA277152

Preclinical studies of non-nucleoside DNMT3A/3B inhibitors

Amount
$200K–$300K
Period
2023-12-19 → 2025-11-30
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01HL149751

Epigenetic regulation of thrombopoiesis

Amount
$300K–$400K
Period
2020-01-01 → 2022-12-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01AI121403

Modeling ICF syndrome in mice: Role of Zbtb24 in DNA methylation and antibody production

Amount
$400K–$500K
Period
2016-09-26 → 2022-08-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01DK106418

Role of Histone H3K9 Methyltransferase Eset in Intestinal Stem Cells

Amount
$300K–$400K
Period
2015-06-01 → 2020-05-31
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R03CA096447

TGF beta receptor type 1 in ovarian cancer

Amount
<$100K
Period
2002-05-01 → 2004-04-30
PIs
1

Awarded at WOOD HUDSON CANCER RESEARCH LAB, INC

Recent Public Signals

  1. New paper: Abstract P49: Target PRMTs to Overcome Cancer Immune Resistance (Cancer Research)2026-07-02
  2. New preprint: Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer2026-04-21
  3. New NIH award: Role of PRMT7 in Genomic Imprinting2023-08-17

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-2524-6440

Professor Insights

Career Trajectory